
Hormonal Therapy Risks Without Surgical Diagnosis: What Patients Should Know
Explore the risks of hormonal therapy without surgical diagnosis for endometriosis. Learn what patients need to know about treatment options and potential side
Discover how Lotus can guide you toward lasting relief.
Explore why patients choose Lotus
Search expert-written answers, browse by topic, or find information based on where you are in your journey.
Explore All KnowledgeReach out and start your healing journey.
Schedule an AppointmentEndometriosis and hormones, evidence-based support for hormonal transitions for those with endo: how to use HRT safely, weigh recurrence and malignancy risks, navigate early or surgical menopause, and manage persistent symptoms after menopause.
Hormonal transitions can reshape how endometriosis behaves. Perimenopause may bring fluctuating pain and bleeding. While natural or surgical menopause lowers estrogen but does not guarantee symptoms will stop. Decisions about hormone replacement therapy (HRT) or estrogen replacement therapy (ERT) must balance relief of hot flashes, sleep disturbance, and bone and heart protection with the small but real and very variable risk of stimulating residual disease. Guidance here focuses on who may benefit, how to reduce recurrence risk, and when to investigate persistent or new symptoms after menopause.
Discover practical ways to personalize HRT—combined estrogen‑progestogen regimens, using a levonorgestrel IUD for local progestin with transdermal estrogen, and why estrogen‑only therapy (ERT) is often avoided after endometriosis, even post‑hysterectomy. Understand timing after surgery, monitoring for red flags, and non‑hormonal options if HRT isn’t suitable. For ongoing pain or bladder/gut symptoms that persist despite menopause, explore complementary strategies in Symptoms & Symptom Control, Medical Management, Mind-Body Practices, and related conditions like Pelvic Floor Dysfunction or Interstitial Cystitis.
Adenomyosis can feel worse during perimenopause for some patients—not because it always “progresses” rapidly, but because hormone fluctuations and changing cycles can amplify the symptoms adenomyosis is known for, especially heavier or more erratic bleeding and worsening cramping or pelvic pressure. As periods become irregular, the pattern of pain may also change, which can be confusing when you’re used to clearly cyclical symptoms.
At the same time, perimenopause doesn’t guarantee worsening. Some people notice symptoms stabilize or improve as they transition fully into menopause, while others continue to have significant pain or bleeding—especially if adenomyosis overlaps with conditions like endometriosis or fibroids. If your symptoms are escalating, we can help clarify what’s driving them (often with targeted ultrasound and, when it matters, MRI) and talk through treatment paths that match your goals, including uterus-preserving options when appropriate and definitive options when they’re not.
Endometriosis excision surgery does not inherently cause early menopause, because menopause is driven by loss of ovarian function—not by removing endometriosis from the pelvis. That said, surgery can impact ovarian reserve in certain situations, especially when endometriosis involves the ovaries (endometriomas) and the procedure requires removing cyst walls or scarred tissue that’s intertwined with healthy ovary.
The biggest menopause-related risk is when an ovary must be removed (oophorectomy) or when ovarian blood supply or tissue is significantly compromised during complex ovarian surgery. Our approach prioritizes meticulous ovarian-sparing excision whenever it’s safe and appropriate, using techniques designed to preserve as much healthy ovarian tissue as possible—while still removing disease at its root.
If you’re worried about early menopause, the most important step is clarifying whether your disease appears ovarian, how many ovaries are involved, and what the realistic surgical plan is (cyst excision vs ovarian preservation vs removal). You can explore more about how we tailor surgery to protect fertility and long-term hormonal health, or reach out to schedule a consultation so we can review your imaging, goals, and risks in detail.
Yes—endometriosis can develop or become noticeable later in life. While many people first have symptoms in the teen years or 20s–30s, endometriosis can show up in peri-menopause, and it can also persist or even appear after menopause (less commonly). The idea that it always “burns out” once periods stop isn’t reliable.
Later-in-life endometriosis may look different than the classic cycle-linked pain. Some people notice more constant pelvic pain, bloating or bowel changes, urinary urgency or bladder discomfort, pain with sex, or even bleeding after menopause. Hormone therapy can sometimes reactivate previously quiet disease, and endometriosis tissue can also produce estrogen locally, which may help it stay active even when ovarian estrogen is low.
If you’re developing new pelvic, bowel, or bladder symptoms as you age—or you’ve had symptoms for years that were never fully explained—our team can help you sort through the possibilities and evaluate for endometriosis and related conditions. If endometriosis is part of the picture, we’ll walk you through what that means and which treatment paths (including minimally invasive excision surgery when appropriate) fit your goals and stage of life.
Not always. While menopause lowers ovarian estrogen and many people do notice improvement, endometriosis can persist—and in some cases symptoms can even begin around peri‑menopause or after periods stop. That’s because endometriosis isn’t only driven by the ovaries; lesions can be highly sensitive to low estrogen levels, and some tissue can produce estrogen locally in the area of disease.
After menopause, symptoms also tend to look less “cyclical” and more like ongoing pelvic pain, bowel or bladder irritation, bloating, painful sex, or occasional bleeding. Hormone therapy can sometimes reactivate symptoms in susceptible patients, and long‑standing disease may leave behind fibrosis/scar tissue that won’t respond to medications. If you’re still having symptoms in peri‑ or post‑menopause, our team can help clarify whether you’re dealing with active endometriosis, adhesions/fibrosis, or another overlapping condition—and discuss whether excision surgery, supportive care, or a tailored plan around hormones makes the most sense.
Many people with adenomyosis can reduce pain and heavy bleeding without a hysterectomy by using anti-inflammatory medications and hormone-based therapies. Common options include a levonorgestrel (progesterone) IUD, oral progestins, or combined birth control pills, chosen based on your symptoms, goals, and how you’ve responded to treatment before. In some cases, short-term use of GnRH agonists or antagonists may be considered to help calm symptoms, especially as a bridge to a longer-term plan.
If medications aren’t enough, uterus-sparing surgery may be an option for select patients, particularly when adenomyosis is more focal and symptoms are persistent. The best approach depends on whether your main issue is bleeding, pain, fertility goals, and whether there are other contributors such as endometriosis or fibroids. Our team can review your imaging, symptoms, and history to map out realistic uterus-preserving options and help you decide what fits your priorities—if you’d like, you can reach out to schedule a consultation.
Adenomyosis symptoms often improve after natural menopause because estrogen levels decline, which can reduce bleeding and uterine cramping. That said, some people continue to have pelvic pain after menopause, especially when other conditions (like endometriosis) or muscular pain patterns are also contributing.
After hysterectomy, adenomyosis itself does not come back because the uterus has been removed. However, persistent or returning pain after treatment doesn’t automatically mean adenomyosis has “returned”—it may reflect another driver of symptoms that needs to be identified. Our team can help sort out what’s most likely in your situation and discuss next steps to support long-term relief.
Yes—diffuse adenomyosis can often be managed without hysterectomy, especially when the goal is symptom control and preserving the uterus. Many patients feel meaningful improvement with hormone-based therapies such as a levonorgestrel (progesterone) IUD, continuous progestins, or GnRH antagonists paired with add-back therapy to reduce side effects.
For pain flares, anti-inflammatory medications may help with cramping, but they don’t treat the underlying disease. In carefully selected cases, uterus-sparing procedures may also be considered, including targeted surgery or uterine artery embolization—each with specific trade-offs, particularly around future fertility and symptom recurrence. Our team can review your symptoms, imaging, and goals to help you understand which non-hysterectomy options are most appropriate and what results you can realistically expect.
Endometrial ablation treats the uterine lining, but adenomyosis lives within the uterine muscle. Because the underlying tissue isn’t removed, ablation often doesn’t resolve adenomyosis-related pain or heavy bleeding, and some patients feel worse afterward.
Ablation is also not appropriate if you want the option of future pregnancy, since it can make carrying a pregnancy unsafe or unlikely. If you’ve been told ablation is an option, our team can help you confirm whether your symptoms and imaging fit adenomyosis and talk through alternatives that better match your goals and severity of symptoms.

Explore the risks of hormonal therapy without surgical diagnosis for endometriosis. Learn what patients need to know about treatment options and potential side

Learn how endometriosis can persist after menopause. Discover symptoms, challenges, and essential research insights for better pain management.

Expert guidance for endometriosis in menopause: HRT options, safe pain relievers, stress reduction, exercise, pelvic floor therapy, and when to seek care.

Learn about postmenopausal endometriosis: who is at risk, diagnosis and treatment basics, and why malignant transformation is rare but worth knowing.

How to use HRT safely with endometriosis: recurrence and malignancy risks, when to start after surgical menopause, and hormone vs non-hormone treatment options.

How endometriosis may be linked to earlier menopause: key evidence, contributing factors, care implications, and practical coping strategies.

Understand postmenopausal endometriosis: why it can persist, symptom management, HRT and phytoestrogen safety, and when surgery is appropriate.
Dr. Steven Vasilev delivers best-in-class endometriosis guidance and a personalized treatment plan—built on evidence and your unique biology.
Led by Steven Vasilev, MD—an internationally recognized endometriosis specialist & MIGS surgeon—Lotus Endometriosis Institute is virtual-forward, with many patients traveling nationally for care. Clinical evaluation and surgical treatment are provided in California.
2121 Santa Monica Blvd, Santa Monica, CA 90404
8:00 am - 5:00 pm
Monday - Friday
154 Traffic Way, Arroyo Grande, CA 93420